HealthcareFDA approves Novoeight BLAOct. 16, 2013 9:13 AM ETNovo Nordisk A/S (NVO) StockNVOBy: Colin Lokey, SA News Editor The FDA approves Novo Nordisk's (NYSE:NVO) BLA for Novoeight. Expected U.S. launch: Q2 2015. Recommended For YouMore Trending NewsSee More »About NVO StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgNVO--Novo Nordisk A/STrending AnalysisTrending News